1. Medtech Insight
  2. >>Policy & Regulation

TransMedics Liver Transplant Device Gets July Panel Date

 
• By Elizabeth Orr

The US FDA panel will look at a PMA for the TransMedics OCS Liver System, which helps keep donor livers stable and healthy as they await transplant.

Liver

Transmedics, Inc. has landed a July advisory committee date with the US Food and Drug Administration, during which the gastroenterology and urology devices panel will take up a PMA for the company’s Organ Care System (OCS) Liver System. The online-only meeting is set for 14 July and will be announced in the 11 June Federal Register.

The OCS Liver System is a portable extracorporeal warm perfusion, assessment and monitoring system that can be used to preserve and monitor donor livers as they await transplant. It’s the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Regulation

More from Policy & Regulation

Inclusive By Design: UK Invites Sponsors To Submit Trial Diversity Plans

 
• By Vibha Sharma

The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.

Plans For Specific EU Orphan And Pediatric Device Expert Panel Need To Go Further

 
• By Amanda Maxwell

Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.